Pfizer offers a high dividend yield of 6.4%, higher than the industry average of 1.7%. Reinvesting dividends could lead to a 10% return. The company’s yield is elevated due to upcoming patent expirations and setbacks in drug development. Despite challenges, Pfizer is actively addressing issues and maintaining its dividend. While the dividend payout ratio is over 100%, Pfizer intends to support the current dividend. Investors may want to trust Pfizer’s history and management’s ability to navigate tough times. The Motley Fool Stock Advisor recommends other stocks over Pfizer for potential high returns.

Read more at Yahoo Finance: This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income